Our results suggest that AOAH plays a regulatory role in ameliorating MASLD and that measures that increase AOAH abundance in the intestine, liver, and/or bloodstream may help prevent this common disease. The gene discussed is AOAH; the disease is metabolic dysfunction-associated steatotic liver disease.